Patent ID: 6235720
Filing Date: 2001-05-22
Classification: A61K,C08F,Y02A

Abstract:
A pharmaceutical composition comprising a polymer and a pharmaceutically acceptable carrier or diluent, wherein the polymer comprises polymerized monomer of Formula II, ##STR3##wherein R.sub.6 is a hydrogen atom or a hydroxyl group, and one of R.sub.2, R.sub.3 and R.sub.4 is an --SO.sub.3 H group or a --CH.sub.2 COOH group or a salt thereof, and the remainder are each a hydrogen atom; or R.sub.6 is --OSO.sub.3 H or --OCH.sub.2 COOH or a salt thereof and R.sub.2, R.sub.3 and R.sub.4 are each a hydrogen atom; the glycoside moiety is an .alpha.- or .beta.-L-glycoside moiety or an .alpha.- or .beta.-D-glycoside moiety; X is a straight chain or branched, substituted or unsubstituted alkylene group, wherein, optionally, one or more carbon atoms are substituted by a heteroatom; Y is CH.sub.2, NH, an oxygen atom or a sulfur atom; Z is an amidocarbonyl, oxycarbonyl, phenylene, amino, aminomethylene, group, or an oxygen atom; and R is a hydrogen atom or a methyl or ethyl group.